High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$4.4M
$4,354,428
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
Other
|
2026-03-03 | $423,987 | M | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
Other
|
2026-03-03 | $456,720 | M | Form 4 |
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
Other
|
2026-03-03 | $720,900 | M | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Diaz Allene M.
• Director
10b5-1 SellΔOwn -66.9%
2026-03-03
$3,106,411Large
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
10b5-1 SellΔOwn -66.9%
|
2026-03-03 | $3,106,411Large | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Diaz Allene M.
• Director
10b5-1 SellΔOwn -75.2%
2026-03-03
$1,166,814Large
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
10b5-1 SellΔOwn -75.2%
|
2026-03-03 | $1,166,814Large | S | Form 4 |
|
IONS
S
IONIS PHARMACEUTICALS INC
Diaz Allene M.
• Director
10b5-1 SellΔOwn -20.9%
2026-03-03
$81,203
|
||||||
| IONS |
IONIS PHARMACEUTICALS INC
|
Director
10b5-1 SellΔOwn -20.9%
|
2026-03-03 | $81,203 | S | Form 4 |